Regeneron Pharmaceuticals, Inc.
2019 Q3 - 2026 Q1 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 29,568 | 0.0% | 38,270 | 3/31/2026 |
| 2025 Q4 | 2/17/2026 | 29,671 | 0.0% | 38,438 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 20,473 | 0.0% | 36,412 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 20,826 | 0.0% | 39,669 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 24,128 | 0.0% | 38,044 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 7,524 | 0.0% | 10,562 | 12/31/2024 |
| 2024 Q3 | 5/4/2026 | 43,449 | 0.0% | 41,331 | 9/30/2024 |
| 2024 Q2 | 5/4/2026 | 48,397 | 0.0% | 46,049 | 6/30/2024 |
| 2024 Q1 | 5/4/2026 | 47,572 | 0.1% | 49,426 | 3/31/2024 |
| 2023 Q4 | 5/4/2026 | 41,616 | 0.1% | 47,383 | 12/31/2023 |
| 2023 Q3 | 5/4/2026 | 39,271 | 0.1% | 47,719 | 9/30/2023 |
| 2023 Q2 | 5/4/2026 | 37,868 | 0.1% | 52,702 | 6/30/2023 |
| 2023 Q1 | 5/4/2026 | 33,184 | 0.1% | 40,386 | 3/31/2023 |
| 2022 Q4 | 5/4/2026 | 21,820 | 0.0% | 30,243 | 12/31/2022 |
| 2022 Q3 | 5/4/2026 | 19,507 | 0.0% | 28,317 | 9/30/2022 |
| 2022 Q2 | 5/4/2026 | 5,260 | 0.0% | 8,898 | 6/30/2022 |
| 2022 Q1 | 5/4/2026 | 4,242 | 0.0% | 6,073 | 3/31/2022 |
| 2021 Q4 | 5/4/2026 | 26,609 | 0.0% | 42,119 | 12/31/2021 |
| 2021 Q3 | 5/4/2026 | 42,434 | 0.1% | 70,118 | 9/30/2021 |
| 2021 Q2 | 5/4/2026 | 22,459 | 0.0% | 40,210 | 6/30/2021 |
| 2021 Q1 | 5/4/2026 | 18,033 | 0.0% | 38,114 | 3/31/2021 |
| 2020 Q4 | 5/4/2026 | 14,055 | 0.0% | 29,197 | 12/31/2020 |
| 2020 Q3 | 5/4/2026 | 20,289 | 0.0% | 36,244 | 9/30/2020 |
| 2020 Q2 | 5/4/2026 | 23,671 | 0.1% | 37,955 | 6/30/2020 |
| 2020 Q1 | 5/4/2026 | 19,975 | 0.1% | 40,908 | 3/31/2020 |
| 2019 Q4 | 5/4/2026 | 20,700 | 0.1% | 55,184 | 12/31/2019 |
| 2019 Q3 | 5/4/2026 | 17,388 | 0.1% | 62,682 | 9/30/2019 |